Literature DB >> 31290492

A potent free fatty acid receptor 1 agonist with a glucose-dependent antihyperglycemic effect.

Xuekun Wang1, Yurui Xu2, Shujun Feng2, Xinyu Huang2, Xia Meng2, Jiao Chen3, Leilei Guo2, Junliang Ge2, Jikang Zhang2, Jianmei Chen2, Li Cheng2, Kai Gu4, Yu Zhang2, Qing Jiang5, Xinghai Ning2.   

Abstract

We present a novel free fatty acid receptor 1 (FFA1) agonist, named PAFA, with a strong agonist potency (EC50 = 6.04 nM) and good serum stability. PAFA significantly stimulates insulin secretion in INS-1 cells in a glucose-dependent manner and exhibits high antihyperglycemic effects in db/db mice without adverse effects.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31290492     DOI: 10.1039/c9cc04040d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  1 in total

1.  Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes.

Authors:  Guoxia Ji; Qinghua Guo; Qidi Xue; Ruifang Kong; Shiben Wang; Kang Lei; Renmin Liu; Xuekun Wang
Journal:  Molecules       Date:  2021-11-16       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.